Tech Company Financing Transactions
Diligent Pharma Funding Round
Diligent Pharma closed a $8.3 million Series A funding round on 5/15/2023. Investors included FCA Venture Partners, GenHenn Venture and PJC.
Transaction Overview
Company Name
Announced On
5/15/2023
Transaction Type
Venture Equity
Amount
$8,270,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to scale its data and content strategy.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
179 Nassau St 3A
Princeton, NJ 08542
USA
Princeton, NJ 08542
USA
Phone
Website
Email Address
Overview
At Diligent we connect clinical research sponsors, CROs, technology and service providers - quickly, efficiently and at very low risk. This can reduce the time taken to start clinical trials by up to 70 days. The cloud-based Diligent Qualification Platform holds comprehensive Request For Information (RFI) details for industry suppliers around the world, as well as Vendor Qualification Assessments (VQAs) audited against latest industry standards.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patricia Leuchten
Chief Technical Officer
LeRoy Jones
Browse more venture capital transactions:
Prev: 5/15/2023: Worldcoin venture capital transaction
Next: 5/15/2023: Figorr (Formerly Gricd) venture capital transaction
Share this article
About Our VC Transactions Data
We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs